ScoreWhy is Zhejiang Haisen Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.10% and Operating profit at 16.19% over the last 5 years
2
Flat results in Mar 26
- INTEREST COVERAGE RATIO(Q) Lowest at 41,761.61
- NET SALES(Q) Lowest at CNY 107.19 MM
- OPERATING PROFIT(Q) Lowest at CNY 32.03 MM
3
With ROE of 8.66%, it has a very attractive valuation with a 0.48 Price to Book Value
- Over the past year, while the stock has generated a return of -12.08%, its profits have risen by 9.7%
- At the current price, the company has a high dividend yield of 0.3
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -12.08% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Haisen Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Haisen Pharmaceutical Co., Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Zhejiang Haisen Pharmaceutical Co., Ltd.
-12.08%
0.43
33.58%
China Shanghai Composite
19.22%
1.40
13.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.10%
EBIT Growth (5y)
16.19%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.34
Tax Ratio
13.44%
Dividend Payout Ratio
12.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.05%
ROE (avg)
8.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.48
EV to EBIT
-2.36
EV to EBITDA
-2.08
EV to Capital Employed
-0.73
EV to Sales
-0.65
PEG Ratio
NA
Dividend Yield
0.26%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
8.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -12.09% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.55 times
-5What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 41,761.61
NET SALES(Q)
Lowest at CNY 107.19 MM
OPERATING PROFIT(Q)
Lowest at CNY 32.03 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 29.88 %
Here's what is working for Zhejiang Haisen Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Highest at 2.55 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -12.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhejiang Haisen Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Lowest at 41,761.61
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Net Sales
Lowest at CNY 107.19 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 32.03 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 29.88 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
